nominally significantP = 0.05
Furthermore, at hospital discharge, we observed a nominally significant increase in the prescription of GLP-1 RA (0.1% vs 0.4%, P = 0.05), whereas no differences were observed in prescriptions of DPP-4 inhibitors, SGLT2 inhibitors, and glinides (Table 3 ).